I Maany

816 total citations
20 papers, 557 citations indexed

About

I Maany is a scholar working on Psychiatry and Mental health, Epidemiology and Pharmacology. According to data from OpenAlex, I Maany has authored 20 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 8 papers in Epidemiology and 6 papers in Pharmacology. Recurrent topics in I Maany's work include Substance Abuse Treatment and Outcomes (8 papers), Schizophrenia research and treatment (5 papers) and Treatment of Major Depression (4 papers). I Maany is often cited by papers focused on Substance Abuse Treatment and Outcomes (8 papers), Schizophrenia research and treatment (5 papers) and Treatment of Major Depression (4 papers). I Maany collaborates with scholars based in United States and Iran. I Maany's co-authors include Vasant Dhopesh, Arthur I. Alterman, Kyle M. Kampman, Alan Frazer, William M. Burke, Woody Ge, O'Brien Cp, McLellan At, J. Mendels and John S. Cacciola and has published in prestigious journals such as American Journal of Psychiatry, The Journal of Clinical Endocrinology & Metabolism and The Journal of Nervous and Mental Disease.

In The Last Decade

I Maany

20 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Maany United States 12 224 223 132 101 94 20 557
Kenneth M. Dürsteler‐MacFarland Switzerland 17 216 1.0× 156 0.7× 81 0.6× 190 1.9× 89 0.9× 37 604
Gail Somer Canada 12 94 0.4× 235 1.1× 82 0.6× 135 1.3× 123 1.3× 19 658
P.J. Geerlings Netherlands 10 279 1.2× 234 1.0× 86 0.7× 52 0.5× 69 0.7× 12 708
Ngamwong Jarusuraisin Thailand 10 423 1.9× 323 1.4× 185 1.4× 117 1.2× 139 1.5× 12 878
Markus Banger Germany 16 101 0.5× 134 0.6× 130 1.0× 40 0.4× 89 0.9× 43 691
Fatima Garawi United States 13 147 0.7× 308 1.4× 303 2.3× 161 1.6× 151 1.6× 13 801
Thorne Sparkman United States 12 247 1.1× 471 2.1× 204 1.5× 69 0.7× 193 2.1× 15 802
T. Y. Slavina Russia 8 149 0.7× 211 0.9× 69 0.5× 127 1.3× 147 1.6× 9 519
Jeffrey Van Kirk United States 10 352 1.6× 298 1.3× 101 0.8× 116 1.1× 93 1.0× 11 758
Otto‐Michael Lesch Austria 13 212 0.9× 226 1.0× 165 1.3× 21 0.2× 140 1.5× 30 710

Countries citing papers authored by I Maany

Since Specialization
Citations

This map shows the geographic impact of I Maany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Maany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Maany more than expected).

Fields of papers citing papers by I Maany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Maany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Maany. The network helps show where I Maany may publish in the future.

Co-authorship network of co-authors of I Maany

This figure shows the co-authorship network connecting the top 25 collaborators of I Maany. A scholar is included among the top collaborators of I Maany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Maany. I Maany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmadi, Jamshid, Malek Ahmadi, Saxby Pridmore, et al.. (2005). Substance Use Disorders in Rheumatic Patients. eCite Digital Repository (University of Tasmania). 8(1). 66–69. 8 indexed citations
2.
Ahmadi, Jamshid, et al.. (2004). Naltrexone for alcohol-dependent patients. Irish Journal of Medical Science (1971 -). 173(1). 34–37. 18 indexed citations
3.
Kampman, Kyle M., Arthur I. Alterman, Joseph R. Volpicelli, et al.. (2001). Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment.. Psychology of Addictive Behaviors. 15(1). 52–59. 109 indexed citations
4.
Kampman, Kyle M., Arthur I. Alterman, Joseph R. Volpicelli, et al.. (2001). Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment.. Psychology of Addictive Behaviors. 15(1). 52–59. 3 indexed citations
5.
Maany, I, et al.. (2000). COMORBIDITY OF PSYCHIATRIC DISORDERS IN IRANIAN TREATMENT-SEEKING OPIOID ADDICTS. 25(12). 25–30. 7 indexed citations
6.
Alterman, Arthur I., Kyle M. Kampman, Chris Boardman, et al.. (1997). A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. Drug and Alcohol Dependence. 46(1-2). 79–85. 78 indexed citations
7.
Dhopesh, Vasant, et al.. (1997). Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine. Psychiatric Services. 48(1). 95–97. 5 indexed citations
8.
Alterman, Arthur I., et al.. (1996). A Quasi-Experimental Comparison of the Effectiveness of 6- versus 12-Hour per Week Outpatient Treatments for Cocaine Dependence. The Journal of Nervous and Mental Disease. 184(1). 54–54. 9 indexed citations
9.
Alterman, Arthur I., et al.. (1994). Reducing waiting time for substance abuse treatment does not reduce attrition. Journal of Substance Abuse. 6(3). 325–332. 11 indexed citations
10.
Dhopesh, Vasant, et al.. (1991). Effect of Cocaine on Thyroid Functions. The American Journal of Drug and Alcohol Abuse. 17(4). 423–427. 10 indexed citations
11.
Dhopesh, Vasant, et al.. (1991). The Relationship of Cocaine to Headache in Polysubstance Abusers. Headache The Journal of Head and Face Pain. 31(1). 17–19. 13 indexed citations
12.
Maany, I, et al.. (1990). Detoxification with phenobarbital of alprazolam-dependent polysubstance abusers. Journal of Substance Abuse Treatment. 7(1). 55–58. 13 indexed citations
13.
Burke, William M., et al.. (1990). Prolonged presence of metabolite in urine after compulsive cocaine use.. PubMed. 51(4). 145–8. 47 indexed citations
14.
Macfadden, Wayne, et al.. (1990). Methadone and edema.. PubMed. 51(1). 36–7. 5 indexed citations
15.
Maany, I, Vasant Dhopesh, I Arndt, et al.. (1989). Increase in desipramine serum levels associated with methadone treatment. American Journal of Psychiatry. 146(12). 1611–1613. 29 indexed citations
16.
Maany, I, et al.. (1989). Urine testing during treatment of cocaine dependence.. PubMed. 95. 320–1. 2 indexed citations
17.
Cp, O'Brien, et al.. (1988). Pharmacological and behavioral treatments of cocaine dependence: controlled studies.. PubMed. 49 Suppl. 17–22. 89 indexed citations
18.
Fuller, Richard K., L. Branchey, Dennis R. Brightwell, et al.. (1987). Disulfiram treatment of alcoholism. A Veterans Administration cooperative study. Journal of Clinical Psychopharmacology. 7(1). 48–48. 39 indexed citations
19.
Maany, I, Joseph Mendels, Alan Frazer, & David J. Brunswick. (1979). A Study of Growth Hormone Release in Depression. Neuropsychobiology. 5(5). 282–289. 24 indexed citations
20.
Maany, I, Alan Frazer, & J. Mendels. (1975). Apomorphine: Effect on Growth Hormone. The Journal of Clinical Endocrinology & Metabolism. 40(1). 162–163. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026